 |
| Global Bacterial Vaccines Market Size |
Bacterial vaccines are developed from killed bacteria or weakened live bacteria
that aid in generating antibodies in the body to fight against various harmful
bacteria. They provide protection against diseases like tetanus, diphtheria,
pertussis, and others. The growing prevalence of diseases like meningitis,
measles, pneumonia, and tuberculosis worldwide has increased the demand for
effective treatment options like bacterial vaccines. The global Bacterial
Vaccines Market is estimated to be valued at US$ 23.77 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends
Development of new vaccines to address unmet medical needs: Major pharmaceutical
companies are focusing on developing novel vaccines for diseases that lack
effective prevention options. For instance, vaccines targeting Group B
Streptococcus (GBS) are under development to prevent GBS infections in
newborns. Similarly, vaccine candidates for diseases like tuberculosis, sepsis,
gonorrhea are in different stages of clinical trials. This focus on expanding
vaccine coverage for more indications is expected to drive the market growth
over the forecast period.
Segment
Analysis
The bacterial vaccines market is segmented by product into pneumococcal, DTP,
influenza, meningococcal, and MMR vaccines. The pneumococcal vaccines segment
dominates the market and accounts for over 30% share of the global bacterial
vaccines market. This is owing to the high prevalence of pneumococcal diseases
and increased government support for routine immunization against pneumococcal
infections.
Key Takeaways
Global Bacterial Vaccines Market Size is
expected to witness high growth over the forecast period of 2023 to 2030.
Regional
analysis: North America region currently dominates the market due to
established healthcare infrastructure and routine immunization programs against
bacterial infections. The Asia Pacific region is poised to grow at the fastest
pace during the forecast period owing to increasing healthcare spending, rising
population, and government initiatives to curb the burden of bacterial
diseases.
Key players
related content comprises: Key players operating in the bacterial vaccines
market are Mondi Group, Kuraray Co. Ltd., Cortec Corporation, Arrow GreenTech
Ltd., AMC (UK) Ltd., Aicello Corporation, Sekisui Chemical Co. Ltd., Neptun
Technologies GmbH, and Mitsubishi Chemical Corporation, among others. The
market is dominated by large scale players like Mondi Group and Kuraray Co.
Ltd. that leverage economies of scale in manufacturing and distribution and
have strong global footprints across major regions.
Get More Insights On This Topic: https://www.newsanalyticspro.com/bacterial-vaccines-market-propelled-by-development-of-new-vaccines/